Concepedia

Publication | Open Access

Efficacy and safety of BAY 81‐8973, a full‐length recombinant factor VIII: results from the LEOPOLD I trial

DOIFull Paper Access

55

Citations

9

References

2016

Year

Kapil Saxena, Shadan Lalezari, Johannes Oldenburg, D. Tseneklidou‐Stoeter, H. Beckmann, Mia Yoon, Monika Maas Enriquez
Haemophilia

Abstract

BAY 81-8973 was efficacious in preventing and treating bleeding episodes, irrespective of the potency assignment method, with few treatment-related AEs. Caution should be used when treating older patients with cardiovascular risk factors.

References

YearCitations

Page 1